Search results
Is Pfizer the Best Dividend Stock for You? | The Motley Fool
The Motley Fool· 5 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (PFE 1.63%) benefitted...
COVID Shot After Acute Coronary Syndrome Might Not Prevent Further Events
MedPage Today· 7 days agoVaccination for COVID-19 after an acute coronary syndrome (ACS) event was not associated with better...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 2 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 6 days agoLorbrena, like Pfizer's Xalkori, is designed to treat cancer with a mutation of a specific gene...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 3 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman Sachs 45th Annual ...
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 1 day agoThis year’s American Society of Clinical Oncology (ASCO) conference in Chicago marked a return to...
Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line
InvestorPlace· 3 days agoAs you approach retirement, it’s crucial to carefully consider your investment portfolio and make...
Moderna's RSV vaccine for older adults approved
Axios· 6 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 6 days agoFood and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot...